According to MarketsandMarkets™, The global next-generation sequencing (NGS) market is projected to grow from USD 13.81 billion in 2026 to USD 27.14 billion by 2031, at a CAGR of 14.5% during the forecast period. The market is expanding rapidly due to increasing demand for NGS-based diagnostics, growing adoption of personalized medicine, and continuous advancements in sequencing technologies that enhance speed, accuracy, and cost efficiency.
Browse 1100 market data Tables and 65 Figures spread through 720 Pages and in-depth TOC on “Next-generation Sequencing Market”.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=546
NGS technologies are becoming integral to both research and clinical applications, including genomics, oncology, infectious disease testing, and population health studies. However, high upfront capital investment required to establish sequencing infrastructure remains a key challenge for market expansion.
Products Segment Leads Market by Offering
By offering, the products segment accounted for the largest share of the NGS market in 2025. This dominance is driven by consistent demand for consumables such as reagents and kits, which generate recurring revenue streams, along with the high cost of sequencing platforms.
While services continue to play a crucial role, particularly in outsourcing high-throughput sequencing needs, products remain the primary revenue contributor across the market.
Sequencing by Synthesis Technology Dominates
By technology, sequencing by synthesis (SBS) held the largest market share in 2025. Its widespread use across genomics, transcriptomics, epigenomics, and metagenomics has contributed to its strong adoption.
The technology’s high accuracy, scalability, and cost-effectiveness make it the preferred choice for a wide range of applications. Other technologies, including ion semiconductor and nanopore sequencing, continue to gain traction, further diversifying the technological landscape.
Sequencing Services Drive Service Segment Growth
Within the services segment, sequencing services accounted for the largest share in 2025. This is largely due to increasing demand from large-scale genomics projects and research programs conducted by governments and private organizations.
Bioinformatics and data analysis services are also witnessing strong growth, supported by the rising complexity and volume of sequencing data, which requires advanced computational tools for interpretation.
Diagnostics Segment Leads Applications
By application, the diagnostics segment held the largest share of the NGS market in 2025. Declining sequencing costs and improved accessibility have enabled broader adoption of NGS in clinical laboratories and hospitals.
NGS is increasingly used in disease diagnosis, including cancer, genetic disorders, and infectious diseases. Large-scale screening initiatives, such as newborn screening and population genomics programs, are further driving demand in this segment.
Academic & Research Institutes Dominate End Users
Academic and research institutes accounted for the largest share of the NGS market by end user in 2025. These institutions are early adopters of advanced sequencing technologies and are heavily involved in exploratory and translational research.
The flexibility of NGS workflows and the growing focus on emerging fields such as single-cell sequencing and spatial transcriptomics continue to drive adoption in academic settings.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=546
North America Leads, Asia Pacific Shows Rapid Growth
North America accounted for the largest share of the global NGS market in 2025, supported by advanced healthcare infrastructure, strong research funding, and early adoption of cutting-edge technologies.
Meanwhile, Asia Pacific is expected to register the highest growth rate during the forecast period. Expanding healthcare infrastructure, increasing investments in genomics research, and rising collaborations among pharmaceutical and biotechnology companies are driving regional growth.
Competitive Landscape
Key players in the NGS market include Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), Revvity (US), Eurofins Scientific (Luxembourg), PacBio (US), Oxford Nanopore Technologies plc. (UK), Takara Bio Inc. (Japan), BGI Group (China), BD (US), 10x Genomics (US), New England Biolabs (US), Promega Corporation (US), Novogene Co., Ltd. (China), LGC Limited (UK), WuXi Biologics (China), MGI Tech Co., Ltd. (China), Tecan Trading AG (Switzerland), Twist Bioscience (US), Azenta US, Inc. (US), GenScript (US), SD Biosensor, Inc. (South Korea), Fulgent Genetics (US), Hamilton Company (US), Zymo Research Corporation (US), NeoGenomics Laboratories (US), and Psomagen (US), among others.
These companies are focusing on product innovation, strategic partnerships, and expansion initiatives to strengthen their market position and support the growing demand for NGS solutions worldwide.
Related Reports:
Genomics Market – Global Forecast to 2030
Next-Generation Sequencing (NGS) Services Market – Global Forecast to 2030
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/next-generation-sequencing-ngs-technologies-market-546.html
Press Release Distributed by ABNewswire.com
To view the original version on ABNewswire visit: Next-Generation Sequencing Market to Reach $27.14 Billion by 2031, Driven by Rising Demand for Precision Diagnostics and Genomics Research
